A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
OL-029 Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
2009
International Journal of Infectious Diseases
Methods: Levels of IL-18 was determined by ELISA in serum from healthy individuals (n=31), HB-immune patients (n=13), anti-HBe positive patients with HBV DNA levels below 10 4 (n=25) or above 10 4 (n=20) copies/ml and HBeAg positive patients with chronic hepatitis B (CHB) (n=14). HBV DNA was assessed by Cobas Amplicor HBV Monitor TM test. IL-18 reactivity was monitored longitudinally in comparison with the viremia in 15 CHB patients treated with interferon-alpha. Results: The serum levels of
doi:10.1016/s1201-9712(09)60358-1
fatcat:vou6wulurbhh7fa4v64kqkdoji